| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/03/2007 | EP1739087A1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 01/03/2007 | EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof |
| 01/03/2007 | EP1738766A1 Preventive and/or therapeutic agent for disease accompanied by chronic muscle/skeleton pain |
| 01/03/2007 | EP1738761A1 Preventive and/or remedy for inflammatory bowel diseases |
| 01/03/2007 | EP1738760A1 Use of biocompatible amphiphilic polymers as an anti-inflammatory agent |
| 01/03/2007 | EP1737857A1 Pyrazolo[3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors |
| 01/03/2007 | EP1737853A1 3-(diheteroarylmethylene)-8-azabicyclo¬3.2.1|octane and 3-((aryl)(heteroaryl)methylene)-8-azabicyclo¬3.2.1|octane derivatives |
| 01/03/2007 | EP1737845A2 Disalt inhibitors of il-12 production |
| 01/03/2007 | EP1737830A1 Tri-substituted ureas as cytokine inhibitors |
| 01/03/2007 | EP1737826A1 Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases |
| 01/03/2007 | EP1737498A2 Zinc finger proteins for treatment of neuropathic pain |
| 01/03/2007 | EP1737471A2 Pharmaceutical compositions and methods of use of lipophilic, silicon-substituted, cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs and derivatives |
| 01/03/2007 | EP1737428A1 Macromolecular delivery systems for non-invasive imaging, evaluation and treatment of arthritis and other inflammatory diseases |
| 01/03/2007 | EP1485098B1 Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo¬1,5-b|pyridazine in nanoparticulate form |
| 01/03/2007 | EP1463487A4 Liposomal delivery of vitamin e based compounds |
| 01/03/2007 | EP1390403B1 Peptides derived from neural thread proteins and their medical use |
| 01/03/2007 | EP1377315B1 Pharmaceutical compositions of rapmycins |
| 01/03/2007 | EP1328319B1 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 01/03/2007 | EP1280798B1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
| 01/03/2007 | EP1267826B1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 01/03/2007 | EP1202963B1 Spla2 inhibitors |
| 01/03/2007 | EP1126839B1 Substituted phenethylsulfones and method of reducing tnf-alpha and pde-iv levels |
| 01/03/2007 | EP1093379B1 Use of inhibitors of protein kinase c epsilon to treat pain |
| 01/03/2007 | EP1071440B1 Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga |
| 01/03/2007 | EP0904090B1 Egg anti-inflammatory composition, method of isolation and use |
| 01/03/2007 | EP0726952B1 Receptor on the surface of activated t-cells:acts-4 |
| 01/03/2007 | CN1890248A Novel compounds |
| 01/03/2007 | CN1890238A Hydronopol derivatives as agonists on human ORL1 receptors |
| 01/03/2007 | CN1890220A A crystalline of the salt form of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing the same |
| 01/03/2007 | CN1890218A Tubulin inhibitors |
| 01/03/2007 | CN1889965A Use of biocompatible polymers for the preparation of a composition or a medical device |
| 01/03/2007 | CN1889964A Enteropathy ameliorating composition |
| 01/03/2007 | CN1887872A Tetrahydro isoquinoline derivative and its prepn process and medicine use |
| 01/03/2007 | CN1887341A Medicine composition for treating chronic osteomyelitis and its prepn |
| 01/03/2007 | CN1887317A Externally applied liniment for treating rheumatic and rheumatoid arthritis and its prepn |
| 01/03/2007 | CN1887312A Chinese medicine composition and its prepn process and quality control method |
| 01/03/2007 | CN1887285A Compound medicine composition and its prepn and use |
| 01/03/2007 | CN1293190C Cell surface molecule mediating cell adhesion and signal transmission |
| 01/03/2007 | CN1293098C Concatameric immunoadhesion |
| 01/03/2007 | CN1293090C 9-alpha-substituted estratrienes as selectively active estrogens |
| 01/03/2007 | CN1293078C Imidazo fused compounds |
| 01/03/2007 | CN1293077C Process for preparing 5-[[2(R)-[1(R)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one |
| 01/03/2007 | CN1293076C Activator for peroxisome proliferator-activated receptor delta |
| 01/03/2007 | CN1293074C Arylindenopyridines with PDE inhibiting activity |
| 01/03/2007 | CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/03/2007 | CN1293061C Novel branched substituted amino derivatives of 3-amino-1-phemyl-1H-[1,2,4]triazo, methods for producing them and pharmaceutica compositions containing them |
| 01/03/2007 | CN1293056C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 01/03/2007 | CN1292767C Compound sichuan lovage rhizome tincture and its preparation process |
| 01/03/2007 | CN1292765C Pharmaceutical composition for treating rheumatoid and rheumatic arthritis, its preparation process and usage |
| 01/03/2007 | CN1292761C Compound defervesce foam for children |
| 01/03/2007 | CN1292759C Treatment of chronic inflammatory diseases with CM 101/GBS toxin |
| 01/03/2007 | CN1292746C Pharmaceutical composition administered orally comprising amino-sulfonyl-containing active compound (COX-2 inhibitors), polyethylene glycol and antioxidate |
| 01/02/2007 | US7157580 Aminopyrimidine and aminopyridine anti-inflammation agents |
| 01/02/2007 | US7157578 4-(2-butylamino)-2, 7-dimethyl-8-(2-methyl-6-methoxypyrid-3-YL) pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 01/02/2007 | US7157498 Diamines having a CaSR modulating activity |
| 01/02/2007 | US7157487 Vla-4 inhibitors |
| 01/02/2007 | US7157469 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 01/02/2007 | US7157467 Therapeutic use |
| 01/02/2007 | US7157464 Substituted piperazines |
| 01/02/2007 | US7157462 Therapeutic agents useful for treating pain |
| 01/02/2007 | US7157457 Compounds useful in the treatment of inflammatory diseases |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 01/02/2007 | US7157436 An specific oligonucleotide sequence conataining 2-20 base 3'OH, 5'OH synthetic oligonucleotide which induces a response selected from cell cycle arrest, inhibition of cell proliferation, activation of caspases in cancer cells |
| 01/02/2007 | US7157433 Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 01/02/2007 | US7157420 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 01/02/2007 | US7157248 Anticonvulsants; anxiolytic agents; multiple sclerosis; isolated nucleic acids; analyzing sample; calibration |
| 01/02/2007 | US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 01/02/2007 | US7157086 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation. |
| 01/02/2007 | US7157081 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis |
| 01/02/2007 | CA2400226C Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 01/02/2007 | CA2376668C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 01/02/2007 | CA2235996C New compounds and their compositions having anti-inflammatory and anti-thrombotic activities |
| 01/02/2007 | CA2218892C Diaromatic propynyl or dienyl compounds |
| 12/29/2006 | CA2551279A1 Use of biocompatible amphiphilic polymers as an anti-inflammatory agent |
| 12/29/2006 | CA2511158A1 Medicated gumstick for treatment in anti-inflammatory conditions and prophylaxis against nsaid gastropathy |
| 12/28/2006 | WO2006138690A2 Improved method of treating degenerative spinal disorders |
| 12/28/2006 | WO2006138373A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
| 12/28/2006 | WO2006138038A1 Intralesional treatment of psoriasis |
| 12/28/2006 | WO2006137472A1 Prostaglandin derivative |
| 12/28/2006 | WO2006137469A1 Metabotropic glutamate receptor activator |
| 12/28/2006 | WO2006137450A1 Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 12/28/2006 | WO2006137435A1 Agonist to g protein-coupled receptor g2a and method of screening g2a activity controller |
| 12/28/2006 | WO2006136917A1 Triazolylpiperidine derivatives and use thereof in therapy |
| 12/28/2006 | WO2006136822A1 Inhibitor compounds |
| 12/28/2006 | WO2006136821A1 Pharmaceutical compounds |
| 12/28/2006 | WO2006136806A1 Thiazolopyrimidines for use in therapy |
| 12/28/2006 | WO2006136033A1 Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy |
| 12/28/2006 | WO2006135973A1 Small molecule glycosaminoglycan mimetics |
| 12/28/2006 | WO2006135969A1 Modulation of sphingosine kinase signalling |
| 12/28/2006 | WO2006135968A1 Modulation of sphingosine kinase signalling |
| 12/28/2006 | WO2006102112A3 Prokineticin 1 receptor |
| 12/28/2006 | WO2006099480A3 Stress proteins and peptides and methods of use thereof |
| 12/28/2006 | WO2006098918B1 Substituted gamma lactams as therapeutic agents |
| 12/28/2006 | WO2006083508A3 Combinations of superoxide dismutase mimetics and nonsteroidal analgesic/anti-inflammatory drugs |
| 12/28/2006 | WO2006081252A3 Use of 1-benzyl-1-hydr0xy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds as analgesics |
| 12/28/2006 | WO2006024958A3 Cannabinoid compositions and methods of use thereof |
| 12/28/2006 | WO2006018698A3 Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract |
| 12/28/2006 | WO2005123192A3 Improving pain treatment with strontium combinations |
| 12/28/2006 | US20060293391 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |